Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.6%

1 terminated out of 61 trials

Success Rate

94.7%

+8.2% vs benchmark

Late-Stage Pipeline

8%

5 trials in Phase 3/4

Results Transparency

0%

0 of 18 completed with results

Key Signals

95% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (23)
P 1 (2)
P 3 (5)

Trial Status

Recruiting19
Completed18
Unknown9
Enrolling By Invitation6
Not Yet Recruiting6
Active Not Recruiting2

Trial Success Rate

94.7%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (61)

Showing 20 of 20 trials
NCT07328243Not ApplicableRecruiting

Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study

NCT05132283Not ApplicableRecruiting

Urologic Lymphadenectomy in AMIGO

NCT07659717Completed

Frozen Section-Guided Selective Ipsilateral Central Neck Dissection in Bethesda V-VI Thyroid Nodules

NCT07625735Not Yet Recruiting

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

NCT07593872Not ApplicableNot Yet Recruiting

XR-Assisted PET/CT Navigation for Cervical Lymph Node Dissection in Lung Cancer

NCT05754814Completed

SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes

NCT07353294Phase 1Enrolling By Invitation

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

NCT06476639Phase 3Not Yet Recruiting

A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer

NCT05970913Active Not Recruiting

PET-CT Predicting Lymph Nodes Metastasis

NCT06252129Not ApplicableRecruiting

Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens

NCT06264167Not ApplicableRecruiting

NODE (groiN ultrasOunD cancEr)

NCT07025785Not ApplicableRecruiting

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

NCT06527027Not ApplicableRecruiting

LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes

NCT06339307Completed

A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients

NCT07161921Completed

Gut Microbiota and Metabolite Signatures Associated With Lymph Node Metastasis in Pancreatic Cancer

NCT06439745Completed

More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated

NCT07050576Recruiting

Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma

NCT06621823Not ApplicableRecruitingPrimary

Image-guided Ultrasound Robotic Intraoperative Evaluation of Lymph-nodes Status in Gynecological Malignancies

NCT06997913Enrolling By InvitationPrimary

Adjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma(AICRC)

NCT06540443Phase 1Recruiting

Pilot Study of MPB-2043 Enhanced MRI for Nodal Staging in Head and Neck Squamous Cell Carcinomas

Scroll to load more

Research Network

Activity Timeline